On April 2, 2025, a working meeting was held between representatives of the National Holding “QazBioPharm” and the French company “Boehringer Ingelheim” (BI). The meeting focused on cooperation in the field of veterinary biosafety and the implementation of a joint Partnership and Supply Agreement.

During the meeting, a wide range of topics was discussed, including joint training programs, quality control, logistics, technical support, and other key areas. Special attention was given to vaccine marketing and quality control.

Additionally, the BI team provided insights into global outbreaks of foot-and-mouth disease (FMD) and offered support in the form of training sessions and data exchange for analytical purposes.

As a result of the meeting, both parties outlined key directions for further collaboration, including preparations for upcoming events planned for 2025-2026.

This meeting marked another significant step in developing the Holding’s sustainable international partnerships in veterinary science and biosafety.